Acid-base and electrolyte disorders in patients with diabetes mellitus
- PMID: 22237220
Acid-base and electrolyte disorders in patients with diabetes mellitus
Abstract
Diabetes mellitus is the most common metabolic disorder in the community. The diabetics may suffer from acid-base and electrolyte disorders due to complications of diabetes mellitus and the medication they receive. In this study, acid-base and electrolyte disorders were evaluated among outpatient diabetics in our hospital. The study consisted of patients with diabetes mellitus who visited the hospital as outpatients between the period January 1, 2004 to December 31, 2006. The patients' medical history, age and type of diabetes were noted, including whether they were taking diuretics and calcium channel blockers or not. Serum creatinine, proteins, sodium, potassium and chloride and blood gases were measured in all patients. Proteinuria was measured by 24-h urine collection. Two hundred and ten patients were divided in three groups based on the serum creatinine. Group A consisted of 114 patients that had serum creatinine < 1.2 mg/dL, group B consisted of 69 patients that had serum creatinine ranging from 1.3 to 3 mg/dL and group C consisted of 27 patients with serum creatinine > 3.1 mg/dL. Of the 210 patients, 176 had an acid-base disorder. The most common disorder noted in group A was metabolic alkalosis. In groups B and C, the common disorders were metabolic acidosis and alkalosis, and metabolic acidosis, respectively. The most common electrolyte disorders were hypernatremia (especially in groups A and B), hyponatremia (group C) and hyperkalemia (especially in groups B and C). It is concluded that: (a) in diabetic outpatients, acid-base and electrolyte disorders occurred often even if the renal function is normal, (b) the most common disorders are metabolic alkalosis and metabolic acidosis (the frequency increases with the deterioration of the renal function) and (c) the common electrolyte disorders are hypernatremia and hypokalemia.
Similar articles
-
Water, electrolyte, acid-base, and trace elements alterations in cirrhotic patients.Int Urol Nephrol. 2018 Jan;50(1):81-89. doi: 10.1007/s11255-017-1614-y. Epub 2017 Jun 12. Int Urol Nephrol. 2018. PMID: 28608260 Review.
-
[Electrolyte and acid-base balance disorders in advanced chronic kidney disease].Nefrologia. 2008;28 Suppl 3:87-93. Nefrologia. 2008. PMID: 19018744 Spanish.
-
Acid-base & electrolytes, practical applications.J Singapore Paediatr Soc. 1981;23(1-2):1-15. J Singapore Paediatr Soc. 1981. PMID: 7343775 No abstract available.
-
Electrolyte disorders in community subjects: prevalence and risk factors.Am J Med. 2013 Mar;126(3):256-63. doi: 10.1016/j.amjmed.2012.06.037. Epub 2013 Jan 18. Am J Med. 2013. PMID: 23332973
-
Acid-base disorders and the kidney.Adv Pediatr. 1983;30:401-71. Adv Pediatr. 1983. PMID: 6424418 Review.
Cited by
-
Behind the Hospital Ward: In-Hospital Mortality of Type 2 Diabetes Mellitus Patients in Indonesia (Analysis of National Health Insurance Claim Sample Data).Int J Environ Res Public Health. 2024 May 1;21(5):581. doi: 10.3390/ijerph21050581. Int J Environ Res Public Health. 2024. PMID: 38791795 Free PMC article.
-
Oxidative Stress-Activated NHE1 Is Involved in High Glucose-Induced Apoptosis in Renal Tubular Epithelial Cells.Yonsei Med J. 2016 Sep;57(5):1252-9. doi: 10.3349/ymj.2016.57.5.1252. Yonsei Med J. 2016. PMID: 27401659 Free PMC article.
-
Unveiling the hidden risks: albumin-corrected anion gap as a superior marker for cardiovascular mortality in type 2 diabetes: insights from a nationally prospective cohort study.Front Endocrinol (Lausanne). 2024 Nov 7;15:1461047. doi: 10.3389/fendo.2024.1461047. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39574951 Free PMC article.
-
Hyponatremia reflects mortality risks other than myocardial damage in acute coronary syndrome.Intern Emerg Med. 2022 Jun;17(4):1235-1237. doi: 10.1007/s11739-021-02915-5. Epub 2022 Jan 23. Intern Emerg Med. 2022. PMID: 35066859 No abstract available.
-
Dialysis-associated hyperglycemia: manifestations and treatment.Int Urol Nephrol. 2020 Mar;52(3):505-517. doi: 10.1007/s11255-019-02373-1. Epub 2020 Jan 18. Int Urol Nephrol. 2020. PMID: 31955362 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical